119-hr795

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 795 Introduced in House

    (IH) ]

<DOC>

119th CONGRESS
 1st Session
 H. R. 795

 To prohibit the Department of Health and Human Services from treating 
 pregnancy as an illness for purposes of approving abortion drugs.

_______________________________________________________________________

 IN THE HOUSE OF REPRESENTATIVES

 January 28, 2025

 Mrs. Miller of Illinois (for herself, Mr. Babin, Mr. Moore of West 
Virginia, Mr. Ogles, Mr. Webster of Florida, Ms. Tenney, Mr. Harris of 
Maryland, and Mr. Weber of Texas) introduced the following bill; which 
 was referred to the Committee on Energy and Commerce

_______________________________________________________________________

 A BILL

 To prohibit the Department of Health and Human Services from treating 
 pregnancy as an illness for purposes of approving abortion drugs.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

 This Act may be cited as the ``Pregnancy Is Not an Illness Act of 
2025''.

SEC. 2. PROHIBITION AGAINST TREATING PREGNANCY AS ILLNESS FOR PURPOSES 
 OF APPROVING ABORTION DRUGS.

    (a) Prohibition.--The Department of Health and Human Services, 
including the Food and Drug Administration, shall not treat pregnancy 
as an illness for purposes of--

    (1) approving any abortion drug under 

section 505 of the 
 Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355); or

    (2) imposing or maintaining any risk evaluation and 
 mitigation strategy for an abortion drug under 

section 505-1 of 
 such Act (21 U.S.C. 355-1).

    (b) Nullification of Approvals in Effect.--

    (1) In general.--Any prohibited approval of an abortion 
 drug is hereby nullified.

    (2) Prohibited approval defined.--In this subsection, the 
 term ``prohibited approval of an abortion drug''--
        (A) means any approval of an abortion drug under 
 

section 505 of the Federal Food, Drug, and Cosmetic Act 
 (21 U.S.C. 355) that relied in whole or in part on the 
 treatment of pregnancy as illness; and
        (B) includes the approval of mifepristone in effect 
 under such 

section 505 on the day before the date of 
 enactment of this Act.
 <all>